High Purity Eloralintide Powder CAS No. 2703710-13-6 Weight Management API
45 Inquiries
2883634-40-8
Pharmaceutical Grade
95%
shanghai
Arshine
5mg 15mg 20mg /vial,Vial/Bottle/Bag/Carton
2026-08-21
cosmetic additives,Veterinary APIs,Feed additives,medical and pharmaceutical packaging materials,pharmaceutical equipment,Natural Nutrition Ingredients
-
Product Description
-
Seller Information
-
Inquiry History
-
DescriptionBasic Info
-
Product Name:
Eloralintide
Other Name:Eloralintide;AMY1176;LY3841136;Eloralintide,LY3841136
CAS No.:2883634-40-8
Molecular Weight:0
EC Number:262-076-3
Color/Form:White to off-white
Categories:
Research-
Class:
Amylin receptor (AMYR) agonist (peptide, long-acting)
Status:Investigational — Phase 1/2 (T2DM and obesity)
Mechanism:Eloralintide is an amylin receptor agonist developed by Eli Lilly for type 2 diabetes and obesity. It activates the amylin receptor (AMYR), reducing food intake, delaying gastric emptying, and promoting satiety. It is structurally distinct from cagrilintide (Novo Nordisk). Being explored as monotherapy and in combination with GLP-1R agonists.
Activity note:Limited public data. Eloralintide is in early clinical development; specific EC50 values have not been publicly disclosed.
Source:MCE: Eloralintide (CAS 2883634-40-8); AbMole product data sheet.
References-
PubChem:Disclaimer:
Eloralintide is NOT FDA-approved or EMA-approved. It is in Phase 1/2 clinical development by Eli Lilly. This listing is for industrial and laboratory research use only. It is not medical advice, a clinical recommendation, or an approved therapy description. Always verify regulatory status, purity, and intended use with the supplier and applicable authorities before purchase or use.
-
-
Seller Information
-
Business Type:
Trader
-
Main Products:
cosmetic additives,Veterinary APIs,Feed additives,medical and pharmaceutical packaging materials,pharmaceutical equipment,Natural Nutrition Ingredients
-
Location:
Factory 401, Building 14, Xinggong Science and Technology Park, No.100 Luyun Road, Changsha High-Tech Development Zone
-
Payment Terms:
TT against copy of documents,D/P,L/C,D/A,O/A,TT against B/L draft before shipment,100% TT in advance
-
Average lead Time:
15
-
Total Annual Revenue:
Above $100 million
-
Total Employees:
201-300
-
Year of Establishment:
2021
-
Certifications:
FAMI-QS,AEO,ISO9001
">
-
-
Inquiry History45 Inquiries
Country Product Purchase Quantity Date Posted
United States
Eloralintide
1 KG May 28, 2026
Bahamas
Eloralintide
10 MT Aug 4, 2026
United States
Eloralintide
2 PCS Aug 2, 2026
United States
Eloralintide
10 PCS Jul 30, 2026
United States
Eloralintide
20 MT Jul 23, 2026
United States
Eloralintide
10 MG Jul 15, 2026
United States
Eloralintide
100 MT Jul 11, 2026
United States
Eloralintide
1 MT Jul 8, 2026
United States
Eloralintide
10 Jul 3, 2026
United States
eloralintide
1 PCS Apr 22, 2026
United Kingdom
Eloralintide
10 MG Mar 14, 2026
United States
Eloralintide
1 G Feb 9, 2026
South Korea
Eloralintide
1 G Nov 14, 2025
United States
eloralintide
10 PCS Nov 12, 2025
Sweden
Eloralinitide
100 PCS Jul 9, 2026
United States
Eloralintide
5 MT Aug 10, 2026
United States
Eloralintide
10 MG Aug 3, 2026
United States
eloralintide
1 PCS Jul 26, 2026
Australia
Eloralintide
15 MG Jul 20, 2026
United States
Eloralintide
1 MT Jul 15, 2026 Post an enquiry for this product